CIK 0000873303 · Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 930797222
- Phone
- 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-08 | Wigzell Hans Lennart Rudolf Director | Sale | −11,745 | $123.10 | $1.4M | 22,940 |
| 2024-03-08 | Wigzell Hans Lennart Rudolf Director | Sale | −100 | $122.39 | $12K | 22,840 |
| 2024-03-08 | Wigzell Hans Lennart Rudolf Director | Option exercise · Stock Option (right to buy) | −15,000 | 0 | ||
| 2024-03-08 | Arif Bilal Chief Tech Ops Officer | Shares withheld for taxes | −472 | $123.14 | $58K | 25,222 |
| 2024-03-08 | Rodino-Klapac Louise Head of R&D, CSO | Shares withheld for taxes | −909 | $123.14 | $112K | 68,073 |
| 2024-03-07 | Arif Bilal Chief Tech Ops Officer | Shares withheld for taxes | −506 | $120.49 | $61K | 25,694 |
| 2024-03-07 | Rodino-Klapac Louise Head of R&D, CSO | Shares withheld for taxes | −512 | $120.49 | $62K | 68,982 |
Page 12 of 12 · 227 trades